User:Mr. Ibrahem/Delavirdine

Delavirdine (DLV), sold under the brand name Rescriptor, is a medication used to treat HIV/AIDS. It is used together with other HIV medicines; though is not a preferred treatment. It is taken by mouth, three times per day.

Common side effects include tiredness, dizziness, headache, and rash. Other symptoms may include Stevens-Johnson syndrome, central obesity, and immune reconstitution syndrome. Safety in pregnancy is unclear. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI).

Delavirdine was approved for medical use in the United States in 1997. It has been discontinued in the United States as of 2021. It is not commonly used.